Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases

  • Authors:
    • Lijie Ma
    • Ruixuan Wang
    • Yandong Nan
    • Wangping Li
    • Qingwei Wang
    • Faguang Jin
  • View Affiliations

  • Published online on: December 21, 2015     https://doi.org/10.3892/ijo.2015.3304
  • Pages: 843-853
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer cases and the prognosis of NSCLC patients is unsatisfactory since 5-year survival rate of NSCLC is still as low as 11%. Natural compounds derived from plants with few or no side effects have been recognized as alternative or auxiliary cure for cancer patients. Phloretin is such an agent possessing various pharmacological activities; however, there is scarce information on its anticancer effects on NSCLC. It was evaluated and confirmed, in the present study, that phloretin inhibited proliferation and induced apoptosis in A549, Calu-1, H838 and H520 cells in a dose-dependent manner, phloretin also suppressed the invasion and migration of NSCLC cells. We further confirmed that phloretin dose-dependently suppressed the expression of Bcl-2, increased the protein expression of cleaved-caspase-3 and -9, and deregulated the expression of matrix metalloproteinases (MMP)-2 and -9 on gene and protein levels. Besides, evaluations revealed that phloretin enhanced the anticancer effects of cisplatin on inhibition of proliferation and induction of apoptosis in NSCLC cells. Moreover, phloretin facilitated the effects of cisplatin on deregulation of Bcl-2, MMP-2 and -9, and upregulation of cleaved-caspase-3 and -9. In conclusion, the present study demonstrated that phloretin possessed anticancer effects and enhanced the anticancer effects of cisplatin on NSCLC cell lines by suppressing proliferation, inducing apoptosis and inhibiting invasion and migration of the cells through regulating apoptotic pathways and MMPs.

References

1 

Subramaniam S, Thakur RK, Yadav VK, Nanda R, Chowdhury S and Agrawal A: Lung cancer biomarkers: State of the art. J Carcinog. 12:32013. View Article : Google Scholar : PubMed/NCBI

2 

Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working Group. Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI

3 

de Boer A, Vos E and Bast A: Implementation of the nutrition and health claim regulation - the case of antioxidants. Regul Toxicol Pharmacol. 68:475–487. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Zicker SC, Wedekind KJ and Jewell DE: Antioxidants in veterinary nutrition. Vet Clin North Am Small Anim Pract. 36:1183–1198. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Mandel S, Amit T, Reznichenko L, Weinreb O and Youdim MB: Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res. 50:229–234. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Yang DS, Li ZL, Peng WB, Yang YP, Wang X, Liu KC, Li XL and Xiao WL: Three new prenylated flavonoids from Macaranga denticulata and their anticancer effects. Fitoterapia. 103:165–170. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Rezk BM, Haenen GR, van der Vijgh WJ and Bast A: The anti-oxidant activity of phloretin: The disclosure of a new antioxidant pharmacophore in flavonoids. Biochem Biophys Res Commun. 295:9–13. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Zhang S and Morris ME: Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther. 304:1258–1267. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Pohl C, Will F, Dietrich H and Schrenk D: Cytochrome P450 1A1 expression and activity in Caco-2 cells: Modulation by apple juice extract and certain apple polyphenols. J Agric Food Chem. 54:10262–10268. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Nguyen H, Zhang S and Morris ME: Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci. 92:250–257. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Boyer J and Liu RH: Apple phytochemicals and their health benefits. Nutr J. 3:52004. View Article : Google Scholar : PubMed/NCBI

12 

Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 18:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Xin M and Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem. 280:10781–10789. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Bayramoglu A, Gunes HV, Metintas M, Değirmenci I, Mutlu F and Alataş F: The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers. 13:671–678. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Yang KC, Tsai CY, Wang YJ, Wei PL, Lee CH, Chen JH, Wu CH and Ho YS: Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol Carcinog. 48:420–431. 2009. View Article : Google Scholar

16 

Nelson JA and Falk RE: Phloridzin and phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in vitro and in vivo. Anticancer Res. 13A:2293–2299. 1993.

17 

Nelson JA and Falk RE: The efficacy of phloridzin and phloretin on tumor cell growth. Anticancer Res. 13A:2287–2292. 1993.

18 

Zhu SP, Liu G, Wu XT, Chen FX, Liu JQ, Zhou ZH, Zhang JF and Fei SJ: The effect of phloretin on human γδ T cells killing colon cancer SW-1116 cells. Int Immunopharmacol. 15:6–14. 2013. View Article : Google Scholar

19 

Karunagaran D, Joseph J and Kumar TR: Cell growth regulation. Adv Exp Med Biol. 595:245–268. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Rong Y and Distelhorst CW: Bcl-2 protein family members: Versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol. 70:73–91. 2008. View Article : Google Scholar

21 

Park HJ, Jeon YK, You DH and Nam MJ: Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol. 60:542–549. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Fennell DA: Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res. 11:2097–2105. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Balzer EM and Konstantopoulos K: Intercellular adhesion: Mechanisms for growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med. 4:171–181. 2012. View Article : Google Scholar

24 

Guruvayoorappan C and Kuttan G: Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol. 30:711–727. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Chen RX, Xia YH, Xue TC, Zhang H and Ye SL: Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Oncol Rep. 25:803–808. 2011.

26 

Borkham-Kamphorst E, Alexi P, Tihaa L, Haas U and Weiskirchen R: Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities. Biochem Biophys Res Commun. 457:307–313. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Davis ME, Gumucio JP, Sugg KB, Bedi A and Mendias CL: MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix. J Appl Physiol. 115:884–891. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Wang R, Ke ZF, Wang F, Zhang WH, Wang YF, Li SH and Wang LT: GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9. Cell Physiol Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Xu X, Chen L, Xu B, Xie Q, Sun M, Deng X, Wu C and Jiang J: Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis. Int J Clin Exp Pathol. 8:1985–1990. 2015.PubMed/NCBI

30 

El-Badrawy MK, Yousef AM, Shaalan D and Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum MMP-9 activity, pathologic type, and prognosis. J Bronchol Interv Pulmonol. 21:327–334. 2014. View Article : Google Scholar

Related Articles

Journal Cover

February 2016
Volume 48 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ma, L., Wang, R., Nan, Y., Li, W., Wang, Q., & Jin, F. (2016). Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases. International Journal of Oncology, 48, 843-853. https://doi.org/10.3892/ijo.2015.3304
MLA
Ma, L., Wang, R., Nan, Y., Li, W., Wang, Q., Jin, F."Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases". International Journal of Oncology 48.2 (2016): 843-853.
Chicago
Ma, L., Wang, R., Nan, Y., Li, W., Wang, Q., Jin, F."Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases". International Journal of Oncology 48, no. 2 (2016): 843-853. https://doi.org/10.3892/ijo.2015.3304